Kathy Y. Yi

2019

In 2019, Kathy Y. Yi earned a total compensation of $1.1M as Former Executive Vice President and Chief Financial Officer at Sangamo Biosciences, a 16% decrease compared to previous year.

Compensation breakdown

Option Awards$692,157
Salary$175,428
Stock Awards$173,828
Other$28,174
Total$1,069,587

Yi received $692.2K in option awards, accounting for 65% of the total pay in 2019.

Yi also received $175.4K in salary, $173.8K in stock awards and $28.2K in other compensation.

Rankings

In 2019, Kathy Y. Yi's compensation ranked 8,984th out of 13,971 executives tracked by ExecPay. In other words, Yi earned more than 35.7% of executives.

ClassificationRankingPercentile
All
8,984
out of 13,971
36th
Division
Manufacturing
3,599
out of 5,701
37th
Major group
Chemicals And Allied Products
1,359
out of 2,200
38th
Industry group
Drugs
1,159
out of 1,886
39th
Industry
Biological Products, Except Diagnostic Substances
262
out of 389
33rd

Pay ratio

Kathy Y. Yi's Pay$1,069,587
Median Employee's Pay$159,900
Pay Ratio

7

to 1

In 2019, the annual total compensation of Kathy Y. Yi was $1,069,587.

The annual total compensation of the median employee at Sangamo Biosciences was $159,900.

The ratio of Kathy Y. Yi's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 1, 2020.

Yi's colleagues

We found six more compensation records of executives who worked with Kathy Y. Yi at Sangamo Biosciences in 2019.

2019

Alexander Macrae

Sangamo Biosciences

Chief Executive Officer

2019

Sung Lee

Sangamo Biosciences

Chief Financial Officer

2019

Adrian Woolfson

Sangamo Biosciences

Executive Vice President, Research and Development

2019

Gary Loeb

Sangamo Biosciences

General Counsel

2019

Stéphane Boissel

Sangamo Biosciences

Chief Financial Officer

2019

R Ramelmeier

Sangamo Biosciences

Executive Vice President, Technical Operations

News

In-depth

You may also like